Design, synthesis and pharmacological evaluation of 4-(3-chloro-4-(3-cyclopropylthioureido)-2-fluorophenoxy)-7-methoxyquinoline-6-carboxamide (WXFL-152): a novel triple angiokinase inhibitor for cancer therapy-Reference-Cited by-同舟云学术

Design, synthesis and pharmacological evaluation of 4-(3-chloro-4-(3-cyclopropylthioureido)-2-fluorophenoxy)-7-methoxyquinoline-6-carboxamide (WXFL-152): a novel triple angiokinase inhibitor for cancer therapy

Published:2020-08 Issue:8 Volume:10 Page:1453-1475
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Yao Yuqin,Liu Zhuowei,Zhao Manyu,Chen Zhengxia,Li Peng,Zhang Yang,Wang Yuxi,Zhao Chengjian,Long Chaofeng,Chen Xiaoxin,Yang Jinliang

Funder

National Major Scientific and Technological Special Project

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference40 articles.

1. VEGFR and type-V RTK activation and signaling;Shibuya;Cold Spring Harbor Perspect Biol,2013

2. Cell signaling by receptor tyrosine kinases;Lemmon;Cell,2010

3. Tumor angiogenesis: therapeutic implications;Folkman;N Engl J Med,1971

4. A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives;Maguire;J Med Chem,1994

5. Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120);Roth;J Med Chem,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis;Biomedicine & Pharmacotherapy;2024-07

2. Discovery of N-(4-((6-(3,5- Dimethoxyphenyl)-9H-purine derivatives as irreversible covalent FGFR inhibitors;European Journal of Medicinal Chemistry;2024-05

3. Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors;Acta Pharmaceutica Sinica B;2023-12

4. Medicinal chemistry strategies in the discovery and optimization of HBV core protein allosteric modulators (2018–2022 update);Chinese Chemical Letters;2023-11

5. Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer;Frontiers in Pharmacology;2023-06-01